Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nan-nan Duan"'
Autor:
Guo-qiang Hu, Yong Yang, Lei Yi, Guo-qiang Wang, Nan-nan Duan, Xiao-yi Wen, Tie-yao Cao, Song-qiang Xie, Wen-Long Huang
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 1, Iss 3, Pp 172-177 (2011)
To contribute to the development of an efficient method for the conversion of antibacterial fluoroquinolones to antitumor fluoroquinolones, a series of C3/C3 bis-fluoroquinolone fused heterocycles cross-linked with a [1,2,4]-triazolo[3,4-b] [1,3,4]-t
Externí odkaz:
https://doaj.org/article/c5455e51e7d7482490bd977b49150eff
Autor:
Yuan-Biao, Qiao, Lan-Fang, Zhang, Qi, Qiao, Jia-Hui, Niu, Ze-Mei, Ren, Hai-Mei, Yang, Chen-Chen, Zhu, Hong-Ju, Pan, Nan-Nan, Duan, Qing-Shan, Li
Publikováno v:
Medical Mycology; Jun2021, Vol. 59 Issue 6, p515-527, 13p
Autor:
Tie Yao Cao, Nan Nan Duan, Wang Wei, Guo Qiang Hu, Xiao Kui Wu, Xiao Yi Wen, Songqiang Xie, Guoqiang Wang, Yin Jun, Wen Long Huang
Publikováno v:
Chinese Chemical Letters. 23:515-517
To further explore an efficient modified route for the shift from an antibacterial fluoroquinolone to an antitumor one, mono-Schiff bases 6a–6h related to ciprofloxacin C3 carbonylhydrazone and bis-Schiff bases 4a–4h corresponding to C3/C7 carbon
Autor:
Songqiang Xie, Yong Yang, Li Li Hou, Xiao Yi Wen, Lei Yi, Tie Yao Chao, Nan Nan Duan, Guo Qiang Hu, Guoqiang Wang, Wen Long Huang
Publikováno v:
Chinese Chemical Letters. 22:804-806
To further expand an effective modified route for the shift from an antibacterial fluoroquinolone (FQ) to an antitumor FQ, two series of title compounds based on an isostere of the FQ C3 carboxylic group with two fused heterocyclic rings, [1,2,4]tria
Autor:
Song-Qiang, Xie, Yin-Sheng, Chen, Guo-Qiang, Wang, Nan-Nan, Duan, Xiao-Yi, Wen, Tie-Yao, Cao, Jun, Yin, Wei, Wang, Guo-Qiang, Hu, Wen-Long, Huang
Publikováno v:
Yao xue xue bao = Acta pharmaceutica Sinica. 47(1)
An efficient modified route based on the targeting mechanism of antibacterial fluoroquinolones for the shift from the antibacterial activity to the antitumor one was further developed. Using a fused heterocyclic ring, s-triazolothiadiazine as a carbo
Autor:
Yuan-Biao Q; Shanxi Key Laboratory of Innovative Drugs for the Treatment of Serious Diseases Basing on Chronic Inflammation, College of Traditional Chinese Medicines, Shanxi University of Chinese Medicine, Taiyuan, Shanxi 030619, P. R. China.; Graduate Institute of Pharmaceutical Chemistry, Luliang University, Luliang, Shanxi 033001, P. R. China., Lan-Fang Z; Shanxi Key Laboratory of Innovative Drugs for the Treatment of Serious Diseases Basing on Chronic Inflammation, College of Traditional Chinese Medicines, Shanxi University of Chinese Medicine, Taiyuan, Shanxi 030619, P. R. China., Qi Q; Department of Medical Biochemistry and Microbiology, Uppsala Biomedical Center, Uppsala University, Husargatan 3, Box 582, SE-751 23 Uppsala, Sweden., Jia-Hui N; Graduate Institute of Pharmaceutical Chemistry, Luliang University, Luliang, Shanxi 033001, P. R. China., Ze-Mei R; Graduate Institute of Pharmaceutical Chemistry, Luliang University, Luliang, Shanxi 033001, P. R. China., Hai-Mei Y; Graduate Institute of Pharmaceutical Chemistry, Luliang University, Luliang, Shanxi 033001, P. R. China., Chen-Chen Z; Graduate Institute of Pharmaceutical Chemistry, Luliang University, Luliang, Shanxi 033001, P. R. China., Hong-Ju P; Graduate Institute of Pharmaceutical Chemistry, Luliang University, Luliang, Shanxi 033001, P. R. China., Nan-Nan D; Graduate Institute of Pharmaceutical Chemistry, Luliang University, Luliang, Shanxi 033001, P. R. China., Qing-Shan L; Shanxi Key Laboratory of Innovative Drugs for the Treatment of Serious Diseases Basing on Chronic Inflammation, College of Traditional Chinese Medicines, Shanxi University of Chinese Medicine, Taiyuan, Shanxi 030619, P. R. China.
Publikováno v:
Medical mycology [Med Mycol] 2020 Sep 01. Date of Electronic Publication: 2020 Sep 01.